SubscribeLogin
Published

PERTHERA ANNOUNCES LANDMARK STUDY SHOWING MULTI-OMIC TESTING’S ROLE IN IMPROVING OUTCOMES FOR METASTATIC BREAST CANCER - Journal of Cyber Policy

Summary by EIN Presswire
MCLEAN, VA, UNITED STATES, November 25, 2024 /EINPresswire.com/ — Perthera, the industry leader in Precision Oncology Decision Support, in collaboration with researchers from George Mason University and The Side-Out Foundation, announces the publication of a groundbreaking study emphasizing the transformative impact of multi-omic molecular testing in guiding treatment for metastatic breast cancer. This pivotal research utilized Perthera’s propri…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

CancerCancer
Breast CancerBreast Cancer
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal